New Jersey, USA -- (SBWire) -- 10/11/2022 --Advance Market Analytics published a new research publication on "AI in Genomics Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the AI in Genomics market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/195312-global-ai-in-genomics-market#utm_source=SBWireLal
Some of the key players profiled in the study are: IBM (United States), Microsoft (United States), NVIDIA Corporation (United States), Data4Cure Inc. (United States), DNAnexus Inc. (United States), Sophia GENETICS (United States), Data4Cure Inc. (United States), Precisionlife Ltd (United Kingdom), Genoox Ltd. (United States), Lifebit (United Kingdom), Diploid (Belgium), MEDGENOME (United States), NetApp, Inc. (United States), FDNA Inc. (United States), Empiric Logic (Ireland), Engine Biosciences Pte. Ltd. (United States), Deep Genomics (Canada), BenevolentAI (United Kingdom), Fabric Genomics Inc. (United States) and Verge Genomics (United States).
Scope of the Report of AI in Genomics
AI in genomics is concerned with the application of artificial intelligence (AI) in the development of computer systems capable of performing tasks such as genome mapping. Furthermore, AI aids in the faster study of the structure, evolution, and activity of genetic material than could be done with human assistance. The primary goal of AI algorithms is to mimic human intelligence; however, in clinical genomics, it is intended to perform genomic analysis such as genome annotation, variant calling, phenotype-to-genotype correspondence, and genome interpretation. Furthermore, AI methods can directly predict protein structure or DNA data with minimal feature handcrafting. The applications of genomics in personalized medicine are significant.
On 13 April 2022, MedGenome Labs, a genomics research and diagnostics company in South Asia, has developed and launched an AI-enabled variant interpretation software suite, VarMiner. According to the company, this software will help clinicians, molecular geneticists, and Genome analysts to interpret and report actionable genetic variants.
The titled segments and sub-section of the market are illuminated below:
by Application (Medical Applications, Agricultural Applications), Technology (Artificial Intelligence, Machine Learning), End User (Hospitals, Research Laboratories, Pharmaceuticals Companies, Biotechnology Companies) Players and Region - Global Market Outlook to 2027
Have Any Questions Regarding Global AI in Genomics Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/195312-global-ai-in-genomics-market#utm_source=SBWireLal
Market Trends:
Rising Number Of Investments In Medical Research
Opportunities:
Increase In Government Initiatives And Research Funding For Promoting Precision Medicines
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
Strategic Points Covered in Table of Content of Global AI in Genomics Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the AI in Genomics market
Chapter 2: Exclusive Summary – the basic information of the AI in Genomics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the AI in Genomics
Chapter 4: Presenting the AI in Genomics Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020
Chapter 6: Evaluating the leading manufacturers of the AI in Genomics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2027)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
finally, AI in Genomics Market is a valuable source of guidance for individuals and companies.
Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/195312-global-ai-in-genomics-market#utm_source=SBWireLal
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia.
